{"id":7068,"date":"2019-11-26T16:13:17","date_gmt":"2019-11-26T07:13:17","guid":{"rendered":"http:\/\/dna.brc.riken.jp\/en\/?page_id=7068"},"modified":"2023-06-09T17:44:59","modified_gmt":"2023-06-09T08:44:59","slug":"reflisten_pa","status":"publish","type":"page","link":"http:\/\/dna.brc.riken.jp\/en\/mailen\/reflisten_pa","title":{"rendered":"BRC DNA resources in Patent application"},"content":{"rendered":"

<\/a><\/p>\n

Scientific journal<\/a><\/h4>\n

When you publish your research results in a scientific journal, please refer to the origin of materials that were provided from RIKEN BRC and used in your research subject. We appreciate your cooperation.
\nExample :<\/p>\n

\n\n\n\n\t
(name of BIOLOGICAL RESOURCE) was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/p>\n

Please also visit NBRP Reference List<\/a>.<\/p>\n<\/blockquote>\n

\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Title<\/th>\nAuther<\/th>\nJournal<\/th>\nNBRP RRC ID<\/th>\n<\/tr>\n
METHOD FOR INDUCING ANTIGEN SPECIFIC CD8 POSITIVE T CELLS<\/td>\nKawamoto, H., Maeda, T., Masuda, K.<\/td>\nPatent publication US 2019 \/ 0161727 A1<\/td>\n1442<\/a><\/td>\n<\/tr>\n
Ckap4-molecular-targeted antitumor agent.<\/td>\nKikuchi, A., Fumoto, K., Kimura, H.<\/td>\nUnited States Patent Application Publication US 2018\/0037649 A1.<\/td>\n985<\/a><\/td>\n<\/tr>\n
CELL CULTURE METHOD, CELL AGGREGATES, CELL AGGREGATION CONTROL AGENT, AND MEDIUM<\/td>\nSakai, Y., Horiguchi, I., Matsunaga, K., Hayasaka, S.<\/td>\nUnited States Patent Application US 2018\/0023057 A1 (2018).<\/td>\n982<\/a><\/td>\n<\/tr>\n
METHOD FOR QUANTIFYING TARGET NUCLEIC ACID AND KIT THEREFOR<\/td>\nHoshino, T., Inagaki, F.<\/td>\nUS 2018\/0320227 A1<\/td>\n1428<\/a><\/td>\n<\/tr>\n
Methods And Materials For Obtaining Hepatocyte Lineage Cells.<\/td>\nTomizawa, M.<\/td>\nUnited States Patent Application Publication US2017\/0218394 A1.<\/td>\n981<\/a><\/td>\n<\/tr>\n
PRODUCTION METHOD FOR PLURIPOTENT STEM CELLS HAVING ANTIGEN-SPECIFIC T CELL RECEPTOR GENE<\/td>\nKawamoto, H., Kaneko, S., Masuda, K., Maeda, T., Nagano, S., Katsura, Y.<\/td>\nUnited States Patent Application Publication US 2017\/0267972 A1.<\/td>\n980<\/a><\/td>\n<\/tr>\n
METHOD OF SCREENING ATP11C OR CDC50A INHIBITOR<\/td>\nNagata, S., Segawa,K.<\/td>\nUS Patent 20,170,023,548, 2017<\/td>\n979<\/a><\/td>\n<\/tr>\n
NUCLEIC ACID-ENCAPSULATING POLYMER MICELLE COMPLEX AND METHOD FOR PRODUCING SAME<\/td>\nKataoka, K., Osada, K., Tockary, T.A.<\/td>\nUS Patent Application Publication US 2016\/0184457 A1<\/td>\n988<\/a><\/td>\n<\/tr>\n
THERAPEUTIC AGENT FOR SYSTEMIC BONE DISEASE AND USE THEREOF<\/td>\nOhno, K., Ishiguro, N.,, Kito, H., Matsushita, M.<\/td>\nUS Patent 20,150,216,860, 2015<\/td>\n991<\/a><\/td>\n<\/tr>\n
METHOD OF PRODUCING MYELOID BLOOD CELLS<\/td>\nSenju, S.<\/td>\nUS Patent 20,130,195,818, 2013<\/td>\n930<\/a><\/td>\n<\/tr>\n
Expression vector<\/td>\nShimatani-Shibata, Y., Yonekura, H.,Shimizu, H.<\/td>\nUnited States Patent Application 20,130,122,582, 2013<\/td>\n <\/td>\n<\/tr>\n
TUMOR GROWTH CONTROLLING METHOD TARGETING GALACTOSYLCERAMIDE EXPRESSION FACTOR-1.<\/td>\nOgura, K.<\/td>\nK Ogura – US Patent 20,130,190,240, 2013<\/td>\n <\/td>\n<\/tr>\n
Coryneform bacterium transformant and process for producing phenol using the same <\/td>\nYukawa, H., Inui, M.<\/td>\nPatent Application Publication WO 2012033112 A1<\/td>\n994<\/a><\/td>\n<\/tr>\n
Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter.<\/td>\nKosai, K., Kamizono, J., Nagano, S.<\/td>\nUnited States Patent Application 20120230954 (2012).<\/td>\n <\/td>\n<\/tr>\n
Nucleic acid construct for expressing oxidative stress indicator and use thereof<\/td>\nTakao IWAWAKI, Daisuke Oikawa<\/td>\nCN103298938A, EP2666857A1, US20130298263<\/td>\n <\/td>\n<\/tr>\n
Viral vector for gene therapy<\/td>\nTani, K., Inoue, H., Inoue, M., Kinoh, H., Hasegawa, M.<\/td>\nUnited States Patent Application, 20100203027 (2010).<\/td>\n <\/td>\n<\/tr>\n
Anaerobic bacterium as a drug for cancer gene therapy.<\/td>\nFujimori, M., Taniguchi, S., Amano, J., Yazawa, K., Kano, Y.<\/td>\nUnited States Patent 7740835; publication data, 06\/22\/2010<\/td>\n <\/td>\n<\/tr>\n
Methods of treatment involving p21\/CIP1<\/td>\nMiyasaka, N., Kohsaka, H.<\/td>\nUnited States Patent Application 20100310508 <\/td>\n <\/td>\n<\/tr>\n
Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter.<\/td>\nKamizono J., Nagano S., Kosai K.<\/td>\nUnited States Patent Application 20090181907 (2009).<\/td>\n <\/td>\n<\/tr>\n
Reversibly immortalized mammalian liver cells and use thereof. <\/td>\nKobayashi, N., Tanaka, N., Kohara, M.<\/td>\nUnited States Patent Application, 20090148424 (2009).<\/td>\n <\/td>\n<\/tr>\n
Method of constructing gene transport support.<\/td>\nShimatani, Y., Hamaji, Y., Matsuhashi, H., Amano, J., Taniguchi, S., Fujimori, M.<\/td>\nUnited States Patent Application 20090169516 (2009).<\/td>\n <\/td>\n<\/tr>\n
Expression vector<\/td>\nShimatani-Shibata, Y., Yonekura, H.,Shimizu, H.<\/td>\nUnited States Patent Application 20090264513 (2009).<\/td>\n <\/td>\n<\/tr>\n
5-Fluorouracil-resistant bacteria and method for production thereof.<\/td>\nHamaji, Y., Fujimori, M., Amano, J., Taniguchi, S.<\/td>\nUnited States Patent Application 20090280091<\/td>\n <\/td>\n<\/tr>\n
Method of measuring human CYP3A inducibility.<\/td>\nYamazoe, Y., Nagata, K.<\/td>\nUnited States Patent Application 20090029351<\/td>\n <\/td>\n<\/tr>\n
PROCESS FOR PRODUCTION OF beta-ALANYLAMINO ACID OR DERIVATIVE THEREOF.<\/td>\nTAKESHITA, R., TAKAKURA, Y., SUZUKI, S., YOKOZEKI, K.<\/td>\nWO2009-139392 (2009).<\/td>\n <\/td>\n<\/tr>\n
THERAPEUTIC AGENT FOR ANAEROBIC DISEASES.<\/td>\nSasaki, T., Shimizu, H., Shimatani-Shibata, Y., Yonekura, H.<\/td>\nUS Patent Application 20110110893, (2011).<\/td>\n <\/td>\n<\/tr>\n
Bone Marrow-Related Cells Associated With Tissue Maintenance And\/Or Repair.<\/td>\nHayashi S. (Nagoya-shi, JP), Inoue M. (Tsukuba-shi, JP), Hasegawa M. (Tsukuba-shi, JP)<\/td>\nUnited States Patent Application 20080038234 (2008).<\/td>\n <\/td>\n<\/tr>\n
Pluripotent stem cell growing method.<\/td>\nAkaike T. (Tokyo, JP), Fukuda K. (Tokyo, JP), Nagaoka M. (Kanagawa, JP), Koshimizu U. (Osaka, JP)<\/td>\nUnited States Patent 7,892,835, (2011); United States Patent Application 20070155013 (2007).<\/td>\n <\/td>\n<\/tr>\n
Blood cholesterol level reducing substance.<\/td>\nSHINSHU UNIV (UICHI IKEDA, MASAFUMI TAKAHASHI, TORU YOSHIOKA, TAKANARI OZAWA, NAOMI OKADA, KAZUYUKI SHIMADA, KIICHI MAEDA, MASAHISA SHINPO)<\/td>\nPatent abstracts of Japan, 2006-028085 (2006).<\/td>\n <\/td>\n<\/tr>\n
Method of proliferating pluripotent stem cell.<\/td>\nAkaike T. (Tokyo, JP) Fukuda K. (Tokyo, JP), Nagaoka M. (Kanagawa, JP), Koshimizu U. (Osaka, JP)<\/td>\nEuropian Patent Application, EP-A1-1734112 (2006).<\/td>\n <\/td>\n<\/tr>\n
Method for proliferating a liver cell, a liver cell obtained thereby, and use thereof.<\/td>\nKobayashi, N., Leboulch, P., Tanaka, N., Fujiwara, T., Totsugawa, T.<\/td>\nUnited States Patent 7033744 (2006)<\/td>\n <\/td>\n<\/tr>\n
Use of geldanamycin and related compounds for treatment of fibrogenic disorders.<\/td>\nStrehlow D.<\/td>\nUnited States Patent Number: 6,887,853. Issued on 05\/03\/2005 to Strehlow.<\/td>\n <\/td>\n<\/tr>\n
Method for efficiently preparing proliferation control type recombinant adenoviral vector and kit for preparing the same vector.<\/td>\nNAGOYA INDUSTRIAL SCIENCE RESEARCH INST (KENICHIRO KOSAI, SATOSHI NAGANO)<\/td>\nPatent abstracts of Japan, 2005-046101 (2005)<\/td>\n <\/td>\n<\/tr>\n
Method of proliferating pluripotent stem cell.<\/td>\nNagaoka M., Koshimizu U., Akaike T., Fukuda K.<\/td>\nCanadian Patent, 2560581 (2005).<\/td>\n <\/td>\n<\/tr>\n
Reversibly immortalized hepatocytes and methods of use.<\/td>\nFox I., LcBoulch P., Kobayashi N.<\/td>\nUnited States Patent Application, 20020081283 (2002).<\/td>\n <\/td>\n<\/tr>\n
Adenovirus vector.<\/td>\nHOKKAIDO TECHNOLOGY LICENCE OFFICE CO LTD (HIROFUMI HAMADA, TAKASHI NAKAMURA)<\/td>\nPatent Abstracts of Japan, 2002-330789 (2002).<\/td>\n <\/td>\n<\/tr>\n
p21Cip1 remedies for rheumatism.<\/td>\nMiyasaka, N., Kohsaka, H.<\/td>\nWIPO, WO2001021793 A1<\/td>\n <\/td>\n<\/tr>\n
Polynucleotide encoding secretory membrane protein.<\/td>\nKimura, N., Toyoshima, T.<\/td>\nUnited States Patent 6271366 (Application 09\/411722) (2001).<\/td>\n <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

go to top<\/a><\/p>\n

(2019.11.25 T.M.)<\/p>\n

2023.06.08<\/p>\n","protected":false},"excerpt":{"rendered":"

Scientific journal When you publish your research results in a scientific journal, please refer to the origin of materials that were provided from RIKEN BRC and used in your research subject. We appreciate your cooperation. Example : Please also visit NBRP Reference List. Title Auther Journal NBRP RRC ID METHOD FOR INDUCING ANTIGEN SPECIFIC CD8 POSITIVE T CELLS Kawamoto, H., Maeda, T., Masuda, K. Patent publication US 2019 \/ 0161727 A1 1442 Ckap4-molecular-targeted antitumor agent. Kikuchi, A., Fumoto, K., Kimura, H. United States Patent Application Publication US 2018\/0037649 A1. 985 CELL CULTURE METHOD, CELL AGGREGATES, CELL AGGREGATION CONTROL AGENT, AND MEDIUM Sakai, Y., Horiguchi, I., Matsunaga, K., Hayasaka, S. United States Patent Application US 2018\/0023057 A1 (2018). 982 METHOD FOR QUANTIFYING TARGET NUCLEIC ACID AND KIT THEREFOR Hoshino, T., Inagaki, F. US 2018\/0320227 A1 1428 Methods And Materials For Obtaining Hepatocyte Lineage Cells. Tomizawa, M. United States Patent Application Publication US2017\/0218394 A1. 981 PRODUCTION METHOD FOR PLURIPOTENT STEM CELLS HAVING ANTIGEN-SPECIFIC T CELL RECEPTOR GENE Kawamoto, H., Kaneko, S., Masuda, K., Maeda, T., Nagano, S., Katsura, Y. United States Patent Application Publication US 2017\/0267972 A1. 980 METHOD OF SCREENING ATP11C OR CDC50A INHIBITOR Nagata, S., Segawa,K. US Patent 20,170,023,548, 2017 […]<\/p>\n","protected":false},"author":13,"featured_media":0,"parent":5580,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-7068","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/7068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/comments?post=7068"}],"version-history":[{"count":3,"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/7068\/revisions"}],"predecessor-version":[{"id":7948,"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/7068\/revisions\/7948"}],"up":[{"embeddable":true,"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/pages\/5580"}],"wp:attachment":[{"href":"http:\/\/dna.brc.riken.jp\/en\/wp-json\/wp\/v2\/media?parent=7068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}